These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 19175673

  • 1. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K, Shin-ya T, Nishio K, Ito F.
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [Abstract] [Full Text] [Related]

  • 2. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y, Li S, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG.
    Cancer Res; 2006 Jan 01; 66(1):404-11. PubMed ID: 16397255
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
    Serini S, Trombino S, Oliva F, Piccioni E, Monego G, Resci F, Boninsegna A, Picci N, Ranelletti FO, Calviello G.
    Apoptosis; 2008 Sep 01; 13(9):1172-83. PubMed ID: 18679798
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
    Zhou Y, Brattain MG.
    Cancer Res; 2005 Jul 01; 65(13):5848-56. PubMed ID: 15994962
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.
    Chan AS, Wong YH.
    Br J Pharmacol; 2004 Jun 01; 142(4):635-46. PubMed ID: 15172963
    [Abstract] [Full Text] [Related]

  • 10. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW, Shi YY, Edmund NA, Somasundaram S, Moore DT, Orlowski RZ.
    Mol Pharmacol; 2004 Dec 01; 66(6):1478-90. PubMed ID: 15448190
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov 01; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY, Small GW, Orlowski RZ.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):33-47. PubMed ID: 16807678
    [Abstract] [Full Text] [Related]

  • 14. Integrin alpha5-induced EGFR activation by prothrombin triggers hepatocyte apoptosis via the JNK signaling pathway.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2008 Aug 01; 216(2):551-7. PubMed ID: 18330891
    [Abstract] [Full Text] [Related]

  • 15. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q, Konta T, Nakayama K, Furusu A, Moreno-Manzano V, Lucio-Cazana J, Ishikawa Y, Fine LG, Yao J, Kitamura M.
    Free Radic Biol Med; 2004 Apr 15; 36(8):985-93. PubMed ID: 15059639
    [Abstract] [Full Text] [Related]

  • 16. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
    Rojo F, González-Navarrete I, Bragado R, Dalmases A, Menéndez S, Cortes-Sempere M, Suárez C, Oliva C, Servitja S, Rodriguez-Fanjul V, Sánchez-Pérez I, Campas C, Corominas JM, Tusquets I, Bellosillo B, Serrano S, Perona R, Rovira A, Albanell J.
    Clin Cancer Res; 2009 May 15; 15(10):3530-9. PubMed ID: 19417026
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.